zlotamajka
03.11.10, 20:38
Monsanto i inne korporacje zdobyly patenty na zastraszajaca ilosc genow w tym na 20% genow czlowieka. Poprzez genetyczna modifikacja niszczona jest roznorodnosc biologiczno-ekologiczna (biodiversity) posrod zboz i innych roslin. Nawet geny swin zostaly opatentowane. Sa plany a raczej program wprowadzenia genetycznie modifikowanych lasow i wypuszczenie genetycznie modifikowanego lososia. To wszystko ma i bedzie mialo katastrofalny wplyw na nasze srodowisko i przyszlosc. Pierwszy raz od poczatku tego genetycznego wariactwa jest malutki krok by odwrocic ta polityke zwiazana z genetyczna modifikacja i patentowaniem genow.
But the U.S. Justice Department has just issued a “friend of the court” briefing that looks poised to overturn this, driving a stake through the heart of the intellectual property monster known as the biotech industry.
This is a major reversal of decades of U.S. policy. If the U.S. Patent and Trademark Office (USPTO) enforces this new ruling, it would mean an end to all biotech patents on human genes. Effectively, it would set our genetic code free from corporate domination.
Human genes are part of nature, not a human invention
In its brief, the Dept of Justice argued that genes should not be patentable because they are part of nature:
“The chemical structure of native human genes is a product of nature, and it is no less a product of nature when that structure is ‘isolated’ from its natural environment than are cotton fibers that have been separated from cotton seeds or coal that has been extracted from the earth…”
www.naturalnews.com/030256_genes_patent_protection.html
Dolaczam tez linki na temat genetycznie modifikowanych lasow i patentowania swin:
www.youtube.com/watch?v=O5rHZE9H7OA
www.youtube.com/watch?v=4-ouf_gmA5o
i swiat wedlug monstanto:
www.youtube.com/watch?v=fvGddgHRQyg
But the U.S. Justice Department has just issued a “friend of the court” briefing that looks poised to overturn this, driving a stake through the heart of the intellectual property monster known as the biotech industry.
